{
    "code": "55007620",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=55007620",
    "time": "2024-01-25 21:21:47",
    "許可證字號": "衛部醫器製字第007620號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QMS0692",
    "有效日期": "117\/12\/18",
    "發證\/登錄日期": "112\/12\/18",
    "許可證\/登錄種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "",
    "中文品名": "台塑生醫家用新型冠狀病毒抗原快速檢驗試劑",
    "英文品名": "Formosa SARS-CoV-2 Antigen Self Test",
    "效能": "本產品是利用免疫分析層析法，定性檢測具新型冠狀病毒肺炎(COVID-19)疑似症狀之急性感染期患者，其鼻腔中新型冠狀病毒的核蛋白。陽性結果無法排除細菌感染或與其他病毒共同感染；陰性結果無法完全排除新型冠狀病毒肺炎感染，不應單以本產品做為治療或管理決策含感染控制的唯一依據。",
    "醫器規格": "1 kit(型號:SC-0001A)、2 kit(型號:SC-0001B)、5 kit(型號:SC-0001C)、20 kit(型號:SC-0001D)，以下空白。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學、病理學及基因學",
    "醫器次類別一": "B4020分析特定試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "01國　產 36GMP",
    "申請商名稱": "台塑生醫科技股份有限公司宜蘭廠",
    "申請商地址": "宜蘭縣礁溪鄉龍潭村龍泉路3號",
    "主製造廠": [
        {
            "製造廠名稱": "台塑生醫科技股份有限公司宜蘭廠",
            "製造廠廠址": "宜蘭縣礁溪鄉龍潭村龍泉路3號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "550076200004-113-01-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=55007620&Seq=002&Type=9"
        },
        {
            "title": "550076200002-113-01-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=55007620&Seq=001&Type=9"
        },
        {
            "title": "550076200001-113-01-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=55007620&Seq=001&Type=8"
        }
    ]
}